Secondary endpoints include the 6-month, 12-month, and 18-month OS rates, progression-free survival, and time to progression at second and third progressive disease (PD), response rate, disease control rates, and duration of response at second and third PD.
Of the patients, 46% had at least one positive sample during the second and third weeks of disease; however, long lasting viraemia was not associated with severe disease (p 0.735 Pearson chi-squared test).
After prodromal gastroenterocolitis, paralytic ileus obviously evolved and was persistent throughout the second and third week of disease.
A previous study reported the temporal progression of clinical and radiologic findings in SARS patients and indicated that several parameters would become more severe in the second and third week of disease (5 ).
Therefore, Fig. 1 shows results (α = 0.05) for haplotypes of length 4 and RR = 6 for one (first column) and two disease loci (second and third columns) under different disease models.
Their median (first and third quartile) disease duration at database entry was 5.1 years (1.3 years and 12.3 years).
The Global Burden of Disease Survey 2010 GBD20100) ranked tension-type headache (TTH) and migraine as the second and third most common diseases worldwide [1].
TTH (estimated global prevalence 20.1%) and migraine (14.7%) ranked respectively as second and third most common diseases in the world (behind dental caries) in both males and females.
According to the Global Burden of Disease Study 2010 GBD 20100), tension-type headache (TTH) and migraine are respectively the second and third most prevalent diseases globally (behind dental caries) [1,2].
In this survey, TTH and migraine, with estimated global prevalences of 20.1% and 14.7% respectively, ranked as second and third most common diseases in the world (behind dental caries) in both males and females.
